Clinical Trials Browser

Phase 1/2 × Immunologic Deficiency Syndromes × Clear all

Agammaglobulinemia, Immunologic Deficiency Syndromes, Infections, Leukopenia, Neutropenia, Warts

NCT06839456 2025-03-25

Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT

Classical hematologyLymphoidOther hematologic neoplasm

Bone Marrow Failure Disorders, Congenital Bone Marrow Failure Syndromes, Anemia, Refractory, with Excess of Blasts, Hemoglobinopathies, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Non-Hodgkin, Metabolism, Inborn Errors

NCT00801931 2019-03-27

Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders

Phase 1/2 Terminated

1 enrolled 8 charts

CNSClassical hematologyLymphoidOther hematologic neoplasm

Anemia, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Neuroblastoma

NCT00179790 2017-03-06

Reduced Intensity Transplant Using Extracorporeal Photopheresis

Phase 1/2 Completed

22 enrolled

Other hematologic neoplasm

Hemoglobinopathies, Immunologic Deficiency Syndromes, Leukemia, Neoplasms

Clinical Trials

A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT

Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders

Reduced Intensity Transplant Using Extracorporeal Photopheresis